Biotech

Companies & Industries

Biotech Companies & Industries Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Top news of the week: 08.11.2023.

Disease
NASDAQ
United States
Moving average
Electrical engineering
Citigroup

@Genetic Engineering & Biotechnology News shared
On Nov 2, 2023
Fake tweet - https://www.investing.com/news/stock-market-news/earnings-call-agco-reports-strong-q3-performance-announces-trimble-joint-venture-93CH-3217249
Open
Earnings call: AGCO reports strong Q3 performance, announces Trimble joint venture

Earnings call: AGCO reports strong Q3 performance, announces Trimble joint venture

Earnings call: AGCO reports strong Q3 performance, announces Trimble joint venture

@Genetic Engineering & Biotechnology News shared
On Nov 3, 2023
Fake tweet - https://news.mit.edu/2023/takeda-fellows-advancing-research-intersection-ai-health-1102
Open
2023-24 Takeda Fellows: Advancing research at the intersection of AI and health

2023-24 Takeda Fellows: Advancing research at the intersection of AI and health

13 new Takeda Fellows for MIT's 2023-24 academic year will conduct pathbreaking research ranging from remote health monitoring for virtual clinical trials to ingestible devices for ...

@Genetic Engineering & Biotechnology News shared
On Nov 4, 2023
Fake tweet - https://www.etfdailynews.com/2023/11/03/seres-therapeutics-inc-nasdaqmcrb-ceo-sells-11545-20-in-stock/
Open
Seres Therapeutics, Inc. (NASDAQ:MCRB) CEO Sells $11,545.20 in Stock

Seres Therapeutics, Inc. (NASDAQ:MCRB) CEO Sells $11,545.20 in Stock

Seres Therapeutics, Inc. (NASDAQ:MCRB – Get Free Report) CEO Eric D. Shaff sold 8,552 shares of the firm’s stock in a transaction on Monday, October 30th. The stock was sold at an average ...

@Genetic Engineering & Biotechnology News shared
On Nov 5, 2023
Fake tweet - https://www.etfdailynews.com/2023/11/04/citizens-financial-group-inc-ri-invests-262000-in-spdr-sp-biotech-etf-nysearcaxbi/
Open
Citizens Financial Group Inc. RI Invests $262,000 in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Citizens Financial Group Inc. RI Invests $262,000 in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Citizens Financial Group Inc. RI purchased a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) in the second quarter, according to its most recent disclosure with the SEC. ...

@Genetic Engineering & Biotechnology News shared
On Nov 2, 2023
Fake tweet - https://www.nationalobserver.com/2023/11/01/news/biotech-firm-aims-breed-tiny-nearly-extinct-lizard
Open
Imagine more dragons: Biotech firm aims to breed this tiny, nearly extinct lizard

Imagine more dragons: Biotech firm aims to breed this tiny, nearly extinct lizard

Colossal Biosciences, which is also behind the bid to bring back the Tasmanian tiger, has teamed up with the Melbourne Zoo to save the 15-centimetre reptile.

@Genetic Engineering & Biotechnology News shared
On Nov 3, 2023
Fake tweet - https://www.cnbc.com/2023/11/02/moderna-mrna-q3-earnings-report-2023.html
Open
Moderna stock falls as sinking Covid vaccine demand drives steep loss

Moderna stock falls as sinking Covid vaccine demand drives steep loss

Moderna's total revenue for the third quarter still topped Wall Street's expectations despite plummeting demand for its Covid-19 shot.

@Genetic Engineering & Biotechnology News shared
On Nov 8, 2023
Fake tweet - https://www.etfdailynews.com/2023/11/07/international-biotechnology-trust-plc-buys-new-position-in-protagonist-therapeutics-inc-nasdaqptgx/
Open
International Biotechnology Trust PLC Buys New Position in Protagonist Therapeutics, Inc. (NASDAQ:PTGX)

International Biotechnology Trust PLC Buys New Position in Protagonist Therapeutics, Inc. (NASDAQ:PTGX)

International Biotechnology Trust PLC bought a new stake in Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Free Report) in the 2nd quarter, according to the company in its most recent Form ...

@Genetic Engineering & Biotechnology News shared
On Nov 8, 2023
Fake tweet - https://www.etfdailynews.com/2023/11/07/international-biotechnology-trust-plc-sells-65000-shares-of-acadia-pharmaceuticals-inc-nasdaqacad/
Open
International Biotechnology Trust PLC Sells 65,000 Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)

International Biotechnology Trust PLC Sells 65,000 Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)

International Biotechnology Trust PLC lowered its position in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) by 30.1% in the second quarter, according to the company in its most ...